Clinical Trial Update: The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating near-infrared fluorescence imaging with indocyanine green to protect the recurrent laryngeal nerve during minimally invasive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Cancer, Recurrent Laryngeal Nerve | Phase 3 | Status: NOT_YET_RECRUITING